216 results on '"Gentet, J.-C."'
Search Results
2. Value of diffusion-weighted images in differentiating mid-course responders to chemotherapy for osteosarcoma compared to the histological response: preliminary results
3. Stratégie de prise en charge de contages tuberculeux dans un service d’oncologie-pédiatrique
4. Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring
5. Atypical teratoid/rhabdoid tumour: 7-year event-free survival with gross total resection and radiotherapy in a 7-year-old boy
6. Accompagnement des enfants atteints de cancers: expérience de l'Association Sourire à la Vie
7. Parental consent in paediatric clinical research
8. Optimizing the surgical management of lung nodules in children with osteosarcoma: Thoracoscopy for biopsies, thoracotomy for resections
9. Subcutaneous lymphoblastic lymphomas. Expression of cellular adhesion molecules: 2 cases
10. A study of 28 flat bone osteosarcomas: prognostic factors and early and long-term outcome
11. 7.P.52 ARE TYROSINE KINASE RECEPTORS GOOD CANDIDATES IN PEDIATRIC OSTEOSARCOMAS FOR TARGETED THERAPIES?
12. New Adaptive Method for Phase I Trials in Oncology
13. Clinical, Radiological, Histopathological, Molecular Description and Identification of Prognostic Factors for Desmoplastic Infantile Gangliogliomas and Astrocytomas: A Multicentric Cohort Study
14. Outcome of Children Treated With Preradiation Chemotherapy for a High-Grade Glioma: Results of a French Society of Pediatric Oncology (SFOP) Pilot Study#
15. Physeal and epiphyseal extent of primary malignant bone tumors in childhood: Correlation of preoperative MRI and the pathologic examination
16. Standard-Risk Medulloblastoma Treated by Adjuvant Chemotherapy Followed by Reduced-Dose Craniospinal Radiation Therapy: A French Society of Pediatric Oncology Study
17. Dose-finding and pharmacokinetic study of weekly oxaliplatin in pediatric solid malignancies: 3257
18. Individual dosing of carboplatin based on drug monitoring in children receiving high-dose chemotherapy
19. Clinical Trials in Paediatric Oncology
20. Les soins intensifs en fin de vie chez les enfants, adolescents et jeunes adultes avec cancer : une étude populationnelle à partir des données du PMSI
21. High-dose methotrexate and HELP [Holoxan (ifosfamide), Eldesine (vindesine), platinum] - doxorubicin in non-metastatic osteosarcoma of the extremity: A French multicentre pilot study
22. Pulmonary anthracosis in children
23. Initial chemotherapy including ifosfamide in the management of Ewing's sarcoma: preliminary results A protocol of the French Pediatric Oncology Society (SFOP)
24. Use of Off-Label Targeted Therapies in Refractory Sarcomas: Analysis of Pediatric Data from the French Registry Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes.
25. CLINICAL TRIALS
26. DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
27. La dyspnée comme symptôme de fin de vie Revue de la littérature
28. Chimiothérapie métronomique en oncologie pédiatrique : effet de mode ou espoir réel ?
29. SFCE-P33 – Cancérologie – Ependymomes intracrâniens de l’enfant et radiothérapie bifractionnée focale post-opératoire
30. Expression de l’ezrine dans les ostéosarcomes centraux de haut grade : corrélations pronostiques
31. Atypical teratoid/rhabdoid tumour: 7-year event-free survival with gross total resection and radiotherapy in a 7-year-old boy
32. Ifosfamide versus cyclophosphamide: Long term gonadal effects in 166 male survivors of childhood cancer
33. Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring
34. Traitement d'une candidose systémique résistante à l'amphotéricine B liposomale par l'ajout de la caspofungine chez un patient neutropénique
35. 246 INVITED Imatinib mesylate in recurrent solid tumours expressing KIT or PDGFR (phase II)
36. Dose finding and O6-alkylguanine-DNA alkyltransferase study of cisplatin combined with temozolomide in paediatric solid malignancies
37. A new IV busulfan fixed dosing for better exposure targeting in children undergoing allogeneic or autologous hematopoietic stem cell transplantation
38. Clinical Trials in Paediatric Oncology
39. Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study)
40. Osteosarcoma
41. Phase I trial and pharmacological study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP study
42. High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study.
43. Ifosfamide and etoposide in childhood osteosarcoma. A phase II study of the french society of paediatric oncology
44. Correlation between polysialic-neural cell adhesion molecule levels in CSF and medulloblastoma outcomes.
45. Etoposide and carboplatin in extraocular retinoblastoma: a study by the Société Française d'Oncologie Pédiatrique.
46. Preirradiation chemotherapy including “eight drugs in 1 day” regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study
47. Etoposide and carboplatin: a highly effective combination in relapsed or refractory Wilms' tumor--a phase II study by the French Society of Pediatric Oncology.
48. Etoposide and carboplatin in neuroblastoma: a French Society of Pediatric Oncology phase II study.
49. No benefit of ifosfamide in Ewing's sarcoma: a nonrandomized study of the French Society of Pediatric Oncology.
50. Ectopic intrapelvic medulloepithelioma: case Report
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.